Alhesain M, Alzubi A, Sankar N, Smith C, Kerwin J, Laws R
Front Neuroanat. 2025; 19:1530236.
PMID: 39990522
PMC: 11842364.
DOI: 10.3389/fnana.2025.1530236.
Chalkiadaki K, Statoulla E, Zafeiri M, Voudouri G, Amvrosiadis T, Typou A
Biol Psychiatry Glob Open Sci. 2025; 5(1):100413.
PMID: 39758604
PMC: 11699409.
DOI: 10.1016/j.bpsgos.2024.100413.
Gergues M, Lalani L, Kheirbek M
Neuropsychopharmacology. 2024; 50(1):274-284.
PMID: 39122815
PMC: 11525937.
DOI: 10.1038/s41386-024-01942-y.
Panza N, Bianchini C, Cetica V, Balestrini S, Barba C, Ferrari A
Epilepsia Open. 2023; 9(1):417-423.
PMID: 37805811
PMC: 10839365.
DOI: 10.1002/epi4.12843.
Naudhani S, Ahmad A, Khan Bazai F, Pervez M, Zafar A, Shah S
Mol Syndromol. 2023; 14(4):293-302.
PMID: 37766826
PMC: 10521233.
DOI: 10.1159/000529427.
Genotype-phenotype correlation in contactin-associated protein-like 2 (CNTNAP-2) developmental disorder.
DOnofrio G, Accogli A, Severino M, Caliskan H, Kokotovic T, Blazekovic A
Hum Genet. 2023; 142(7):909-925.
PMID: 37183190
PMC: 10329570.
DOI: 10.1007/s00439-023-02552-2.
Intermittent hypoxia-induced enhancement of sociability and working memory associates with CNTNAP2 upregulation.
Zhang Q, Xu L, Bai Y, Chen P, Xing M, Cai F
Front Mol Neurosci. 2023; 16:1155047.
PMID: 37089693
PMC: 10118049.
DOI: 10.3389/fnmol.2023.1155047.
A Pilot Study of Whole-Blood Transcriptomic Analysis to Identify Genes Associated with Repetitive Low-Level Blast Exposure in Career Breachers.
Vorn R, Edwards K, Hentig J, Yun S, Kim H, Lai C
Biomedicines. 2022; 10(3).
PMID: 35327492
PMC: 8945695.
DOI: 10.3390/biomedicines10030690.
Genome and Transcriptome Assembly of the Canadian Beaver ().
Lok S, Paton T, Wang Z, Kaur G, Walker S, Yuen R
G3 (Bethesda). 2017; 7(2):755-773.
PMID: 28087693
PMC: 5295618.
DOI: 10.1534/g3.116.038208.
Characterisation of CASPR2 deficiency disorder--a syndrome involving autism, epilepsy and language impairment.
Rodenas-Cuadrado P, Pietrafusa N, Francavilla T, La Neve A, Striano P, Vernes S
BMC Med Genet. 2016; 17:8.
PMID: 26843181
PMC: 4739328.
DOI: 10.1186/s12881-016-0272-8.
CNTNAP2 gene in high functioning autism: no association according to family and meta-analysis approaches.
Werling A, Bobrowski E, Taurines R, Gundelfinger R, Romanos M, Grunblatt E
J Neural Transm (Vienna). 2015; 123(3):353-63.
PMID: 26559825
DOI: 10.1007/s00702-015-1458-5.
PECONPI: a novel software for uncovering pathogenic copy number variations in non-syndromic sensorineural hearing loss and other genetically heterogeneous disorders.
Tsai E, Berman M, Conlin L, Rehm H, Francey L, Deardorff M
Am J Med Genet A. 2013; 161A(9):2134-47.
PMID: 23897863
PMC: 3745548.
DOI: 10.1002/ajmg.a.36038.
Shining a light on CNTNAP2: complex functions to complex disorders.
Rodenas-Cuadrado P, Ho J, Vernes S
Eur J Hum Genet. 2013; 22(2):171-8.
PMID: 23714751
PMC: 3895625.
DOI: 10.1038/ejhg.2013.100.
CNTNAP2 and language processing in healthy individuals as measured with ERPs.
Kos M, van den Brink D, Snijders T, Rijpkema M, Franke B, Fernandez G
PLoS One. 2012; 7(10):e46995.
PMID: 23115634
PMC: 3480372.
DOI: 10.1371/journal.pone.0046995.
What does CNTNAP2 reveal about autism spectrum disorder?.
Penagarikano O, Geschwind D
Trends Mol Med. 2012; 18(3):156-63.
PMID: 22365836
PMC: 3633421.
DOI: 10.1016/j.molmed.2012.01.003.